Clinical relevance of circulating tumor cells (CTC) in primary and metastatic breast cancer

被引：0
|
作者：
Fehm, T.
机构：
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(09)72115-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [41] Concordance of genomic alterations with targeted sequencing of circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) in endocrine-resistant metastatic breast cancer
    Ayala de la Pena, F.
    Navarro Manzano, E.
    Fernandez Perez, M. P.
    Garcia Martinez, E.
    de la Morena Barrio, P.
    Ivars Rubio, A.
    Gonzalez Billalabeitia, E.
    Fernandez Sanchez, A.
    Teruel Montoya, R.
    Marin Zafra, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [42] Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
    Davis, Andrew A.
    Zhang, Qiang
    Gerratana, Lorenzo
    Shah, Ami N.
    Zhan, Youbin
    Qiang, Wenan
    Finkelman, Brian S.
    Flaum, Lisa
    Behdad, Amir
    Gradishar, William J.
    Platanias, Leonidas C.
    Cristofanilli, Massimo
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [43] Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
    Andrew A. Davis
    Qiang Zhang
    Lorenzo Gerratana
    Ami N. Shah
    Youbin Zhan
    Wenan Qiang
    Brian S. Finkelman
    Lisa Flaum
    Amir Behdad
    William J. Gradishar
    Leonidas C. Platanias
    Massimo Cristofanilli
    Breast Cancer Research, 21
  • [44] Crculating tumor cell (CTC) assays in primary and metastatic breast cancer: comparative results and clinical implications.
    Krishnan, KJ
    Scott, J
    Frey, T
    Bauer, K
    Ewing, C
    Hwang, ESS
    Campbell, MJ
    Esserman, LJ
    Park, JW
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S99 - S99
  • [45] Presence of circulating tumor cells (CTC) in metastatic breast cancer (MBC) predicts rapid progression and poor prognosis.
    Cristofanilli, M
    Budd, GT
    Ellis, MJ
    Stopeck, A
    Matera, J
    Miller, MC
    Doyle, GV
    Allard, WJ
    Terstappen, LW
    Hayes, DF
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 9S - 9S
  • [46] Circulating tumor cells in solid cancer: Tumor marker of clinical relevance?
    Loris Bertazza
    Simone Mocellin
    Donato Nitti
    Current Oncology Reports, 2008, 10 : 137 - 146
  • [47] Circulating Tumor Cells in Solid Cancer: Tumor Marker of Clinical Relevance?
    Bertazza, Loris
    Mocellin, Simone
    Nitti, Donato
    CURRENT ONCOLOGY REPORTS, 2008, 10 (02) : 137 - 146
  • [48] Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
    Muraro, Elena
    Del Ben, Fabio
    Turetta, Matteo
    Cesselli, Daniela
    Bulfoni, Michela
    Zamarchi, Rita
    Rossi, Elisabetta
    Spazzapan, Simon
    Dolcetti, Riccardo
    Steffan, Agostino
    Brisotto, Giulia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Clinical safety of diagnostic leukapheresis as a liquid biopsy to collect circulating tumor cells in primary and metastatic breast cancer patients
    Fehm, T.
    Meier-Stiegen, F.
    Jaeger, B.
    Reinhardt, F.
    Naskou, J.
    Franken, A.
    Neubauer, H.
    Driemel, C.
    Ruckhaeberle, E.
    Niederacher, D.
    Fischer, J.
    Stoecklein, N.
    CANCER RESEARCH, 2019, 79 (04)
  • [50] Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker (Review)
    Ren, Chuanli
    Han, Chongxu
    Wang, Daxin
    Zhao, Xiaohang
    Jin, Guangfu
    Shen, Hongbing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (03) : 385 - 391
12345